Sara Svensson Akusjärvi

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2023;120(37):e2304722120
Systems-level temporal immune- metabolic profile in Crimean-Congo hemorrhagic fever virus infection
Ambikan AT; Elaldi N; Akusjaervi SS; Bagci B; Pektas AN; Hewson R; Bagci G; Arasli M; Appelberg S; Mardinoglu A; Sood V; Vegvari A; Benfeitas R; Gupta S; Cetin I; Mirazimi A; Neogi U
Article: AIDS. 2023;37(7):1023-1033
Role of myeloid cells in system-level immunometabolic dysregulation during prolonged successful HIV-1 treatment
Svensson Akusjarvi S; Krishnan S; Ambikan AT; Mikaeloff F; Munusamy Ponnan S; Vesterbacka J; Lourda M; Nowak P; Sonnerborg A; Neogi U
Article: CURRENT HIV/AIDS REPORTS. 2023;20(2):42-50
Biological Aging in People Living with HIV on Successful Antiretroviral Therapy: Do They Age Faster?
Akusjaervi SS; Neogi U
Article: LIFE SCIENCE ALLIANCE. 2022;5(9):e202201405
Genome-scale metabolic models for natural and long-term drug-induced viral control in HIV infection
Ambikan AT; Svensson-Akusjarvi S; Krishnan S; Sperk M; Nowak P; Vesterbacka J; Sonnerborg A; Benfeitas R; Neogi U
Article: CELL SYSTEMS. 2022;13(8):665-681.e4
Multi-omics personalized network analyses highlight progressive disruption of central metabolism associated with COVID-19 severity
Ambikan AT; Yang H; Krishnan S; Akusjarvi SS; Gupta S; Lourda M; Sperk M; Arif M; Zhang C; Nordqvist H; Ponnan SM; Sonnerborg A; Treutiger CJ; O'Mahony L; Mardinoglu A; Benfeitas R; Neogi U
Article: ELIFE. 2022;11:e76071
Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target
Neogi U; Elaldi N; Appelberg S; Ambikan A; Kennedy E; Dowall S; Bagci BK; Gupta S; Rodriguez JE; Svensson-Akusjarvi S; Monteil V; Vegvari A; Benfeitas R; Banerjea A; Weber F; Hewson R; Mirazimi A
Article: COMMUNICATIONS BIOLOGY. 2022;5(1):357
Peripheral blood CD4⁺CCR6⁺ compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals
Svensson Akusjarvi S; Krishnan S; Jutte BB; Ambikan AT; Gupta S; Rodriguez JE; Vegvari A; Sperk M; Nowak P; Vesterbacka J; Svensson JP; Sonnerborg A; Neogi U
Article: ISCIENCE. 2022;25(1):103607
Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling
Akusjarvi SS; Ambikan AT; Krishnan S; Gupta S; Sperk M; Vegvari A; Mikaeloff F; Healy K; Vesterbacka J; Nowak P; Sonnerborg A; Neogi U
Article: COMMUNICATIONS BIOLOGY. 2022;5(1):27
Trans cohort metabolic reprogramming towards glutaminolysis in long-term successfully treated HIV-infection
Mikaeloff F; Akusjarvi SS; Ikomey GM; Krishnan S; Sperk M; Gupta S; Magdaleno GDV; Escos A; Lyonga E; Okomo MC; Tagne CT; Babu H; Lorson CL; Vegvari A; Banerjea AC; Kele J; Hanna LE; Singh K; de Magalhaes JP; Benfeitas R; Neogi U
Article: AGING. 2021;13(19):22732-22751
The central role of the glutamate metabolism in long-term antiretroviral treated HIV-infected individuals with metabolic syndrome
Gelpi M; Mikaeloff F; Knudsen AD; Benfeitas R; Krishnan S; Akusjarvi SS; Hogh J; Murray DD; Ullum H; Neogi U; Nielsen SD
Article: ISCIENCE. 2021;24(2):102111
Distinct lipid profile, low-level inflammation, and increased antioxidant defense signature in HIV-1 elite control status
Sperk M; Mikaeloff F; Svensson-Akusjarvi S; Krishnan S; Ponnan SM; Ambikan AT; Nowak P; Sonnerborg A; Neogi U
Article: MOLECULAR & CELLULAR PROTEOMICS. 2021;20:100159
Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication
Krishnan S; Nordqvist H; Ambikan AT; Gupta S; Sperk M; Svensson-Akusjarvi S; Mikaeloff F; Benfeitas R; Saccon E; Ponnan SM; Rodriguez JE; Nikouyan N; Odeh A; Ahlen G; Asghar M; Sallberg M; Vesterbacka J; Nowak P; Vegvari A; Sonnerborg A; Treutiger CJ; Neogi U
Article: EMERGING MICROBES AND INFECTIONS. 2020;9(1):1748-1760
Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells
Appelberg S; Gupta S; Svensson Akusjarvi S; Ambikan AT; Mikaeloff F; Saccon E; Vegvari A; Benfeitas R; Sperk M; Stahlberg M; Krishnan S; Singh K; Penninger JM; Mirazimi A; Neogi U
Article: PLOS PATHOGENS. 2020;16(1):e1008264
Chromatin maturation of the HIV-1 provirus in primary resting CD4⁺ T cells
Lindqvist B; Akusjarvi SS; Sonnerborg A; Dimitriou M; Svensson JP
Article: FRONTIERS IN IMMUNOLOGY. 2019;10:1965
Systemic Inflammation and the Increased Risk of Inflamm-Aging and Age-Associated Diseases in People Living With HIV on Long Term Suppressive Antiretroviral Therapy
Babu H; Ambikan AT; Gabriel EE; Akusjarvi SS; Palaniappan AN; Sundaraj V; Mupanni NR; Sperk M; Cheedarla N; Sridhar R; Tripathy SP; Nowak P; Hanna LE; Neogi U
Article: FRONTIERS IN MICROBIOLOGY. 2018;9:2358
Characterization of Inducible Transcription and Translation-Competent HIV-1 Using the RNAscope ISH Technology at a Single-Cell Resolution
Zhang W; Akusjarvi SS; Sonnerborg A; Neogi U
Article: FRONTIERS IN PHARMACOLOGY. 2017;8:433
Phenotypic Screening Identifies Synergistically Acting Natural Product Enhancing the Performance of Biomaterial Based Wound Healing
Sivasubramanian S; Chandrasekar G; Akusjarvi SS; Thangam R; Sathuvan M; Kumar RBS; Hussein H; Vincent S; Madhan B; Gunasekaran P; Kitambi SS

Alla övriga publikationer

Thesis / dissertation: 2022
Immunometabolic reprogramming during suppressive HIV-1 infection
Svensson Akusjärvi, Sara
Review: DRUG DESIGN, DEVELOPMENT AND THERAPY. 2017;11:1957-1967
Cell and small animal models for phenotypic drug discovery
Szabo M; Akusjarvi SS; Saxena A; Liu J; Chandrasekar G; Kitambi SS

Anställningar

Postdoktor, Medicin, Solna, Karolinska Institutet, 2023-2025

Examina och utbildning

Medicine Doktorsexamen, Institutionen för laboratoriemedicin, Karolinska Institutet, 2022

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI